Sally Hodder, MD

Associate Vice President, Clinical and Transitional Research, Professor of Medicine, Director, West Virginia Clinical and Translational Science Institute, West Virginia University, Morgantown, WV

Dr. Hodder is an infectious diseases physician with 30 years of experience, spanning both academia and the pharmaceutical industry. She is currently Professor of Medicine, Director of the West Virginia Clinical and Translational Science Institute, and Associate Vice President for Clinical and Translational Research at West Virginia University. Dr. Hodder received her undergraduate degree in 1976 from Mount Holyoke College, graduating Magna Cum Laude with a major in chemistry. She attended Case Western Reserve University School of Medicine (Cleveland, Ohio), graduating in 1980, Alpha Omega Alpha and winner of the Alice B. Cleveland Prize for leadership. After completing residency training in internal medicine and infectious diseases and serving as Chief Medical Resident at University Hospitals of Cleveland, she joined the faculty of the Department of Medicine at Case Western Reserve University School of Medicine. International experience as a junior faculty member included working in Coast Province, Kenya, assessing impact of praziquantel therapy on obstructive uropathy among patients with Schistosoma haematobium. Dr. Hodder also successfully competed for and completed an NIH K award in the area of tuberculosis In 2000, Dr. Hodder accepted a position in the Virology franchise of Bristol-Myers-Squibb, and subsequently was promoted to Vice President of Virology Medical Affairs, a position in which she was responsible for administering a $47 MM annual budget and 50-member department that included clinical trials management, medical information, and a field medical science liaison force. In 2005, Dr. Hodder was recruited to New Jersey Medical School, in Newark to build an HIV program in a community where the HIV prevalence was nearly 3% but where (at that time) there was not an active NIH Division of AIDS adult trial site. During her tenure in Newark, HIV program funding quadrupled and NIH supported HIV prevention and treatment trials were implemented. In 2014, Dr. Hodder was recruited to West Virginia University to direct the West Virginia Clinical and Translational Science Institute whose mission is to build biomedical translational research relevant to West Virginia. In May 2015, Dr. Hodder was promoted to Associate Vice President of Clinical and Translational Research at WVU. Dr. Hodder has served and continues to serve on numerous national committees including the Institute of Medicine Committee on Methodological Challenges in HIV Prevention Trials, and most recently she was appointed by Secretary Burwell to the Council of the National Institutes of Allery and Infectious Diseases. She has authored many scientific papers and book chapters in the areas of infectious diseases and women’s health. In acknowledgment of her efforts in the field of infectious diseases, Dr. Hodder has been awarded numerous honors including the Culver Educational Foundation Woman of the Year (the first woman to receive this honor), New Philadelphia High School (New Philadelphia, Ohio) Distinguished Service Award, New Jersey Medical School Faculty of the Year, and New Jersey Medical School Research Excellence Award.